FDA REJECTS BIOGEN’S ALZHEIMER’S DRUG ON LACK OF EVIDENCE
Highlights • The panel of outside experts agreed that a pivotal study in patients failed to show substantial evidence on effectiveness of the drug • This experimental drug was developed by Biogen and called as aducanumab, which doesn’t cure or…
